Physician profile
David E Michalik
NPI 1194842344
$5,474.68
in general payments reported to CMS, 2019-2025
16 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Pediatric Infectious Diseases provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $642 · 2020: $573 · 2021: $646 · 2022: $1,975 · 2023: $596 · 2024: $757 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,638.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,476.18 | 2019-2025 | Sunlenca, Biktarvy |
| Partner Therapeutics, INC. | $1,356.88 | 2022 | |
| Viiv Healthcare Company | $1,022.88 | 2019-2025 | Dovato, Cabenuva |
| Janssen Biotech, INC. | $761.46 | 2019-2023 | Symtuza |
| Merck Sharp & Dohme LLC | $247.92 | 2019-2025 | Pifeltro, Delstrigo |
| Horizon Therapeutics Plc | $140.68 | 2021 | |
| Janssen Products, LP | $99.99 | 2019 | |
| Allergan, INC. | $83.44 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $55.70 | 2020-2021 | |
| Emd Serono, INC. | $50.98 | 2019-2025 | |
| Pfizer INC. | $47.41 | 2020-2021 | |
| Insmed, INC. | $37.65 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Sanofi Pasteur INC. | $26.81 | 2023 | |
| Abbvie INC. | $19.13 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $19.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Michalik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.